drugset / Trial / NCT05905120

Assessing Dopamine Transporter Occupancy in the Healthy Adult Brain With Toludivenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)

NCT05905120 ↗

NaSingle-groupOpen-labelTreatment

Summary

This study was a single-arm, non-randomized, open-label clinical study to assess dopamine transporter occupancy in the brain of healthy adults using 11C-CFT positron emission tomography (PET)

Timeline

Start
2023-03-02
Primary completion
2023-06-30
Completion
2023-07-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Toludivenlafaxine Unknown 160 mg Oral